Healthcare -
Biotechnology - NASDAQ - US
$ 6.42
1.42 %
$ 570 M
Market Cap
-2.73
P/E
Price Target
Average
214.64%
Revenue Forecast
Estimate
4.97%
EBIT
Estimate
26.25%
Net Income
Estimate
--2.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verve Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for VERV of $20.2 , with forecasts ranging from
a
low of
$13 to a high of $30 .
VERV Lowest Price Target
Wall Street Target
13 USD
102.49%
VERV Average Price Target
Wall Street Target
20.2 USD
214.64%
VERV Highest Price Target
Wall Street Target
30 USD
367.29%
REVENUE FORECAST
Revenue Forecast Chart VERV
EBIT FORECAST
EBIT Forecast Chart VERV
NET INCOME FORECAST
Net Income Chart VERV